Tweet
Our department is looking for a software solution to support analysis and reporting of somatic cancer variants (currently panels, but eventually exomes). It looks like most of the currently available reporting software (Cartagenia, Next Code) is designed to support germline analysis (rare disease analysis). We would be interested in any software packages that are available to specifically support somatic cancer variant analysis. Know of any?
-
-
Gerald -- I work at GenomOncology. We offer a Clinical Workbench, installed within your firewall, where the input is the BAM/VCF and QC files to enable professional interpretation (in a high-assurance fully traceable and audit-able manner) and generate a clinically actionable report in less than 20 minutes from start to finish. The report is template driven and 100% customizable to your labs needs.
Vanderbilt’s MyCancerGenome, plus FDA, NCCN and ACSO guidelines, drive the clinical interpretation and also allows the lab to add relevant Clinical Trials and content. We have an exclusive license for MyCancerGenome and a solid relationship with the Vanderbilt team. If your institution has its own rules, those can easily be added too.
Feel free to message me -- I'm happy to talk further. -
WuXi NextCODE support somatic cancer
Hi Gerald, I am with WuXi NextCODE. We do support somatic cancer. If you want a demo, please let me know. I am happy to walk you through it.Comment
-
The field of epigenetics has traditionally concentrated more on DNA and how changes like methylation and phosphorylation of histones impact gene expression and regulation. However, our increased understanding of RNA modifications and their importance in cellular processes has led to a rise in epitranscriptomics research. “Epitranscriptomics brings together the concepts of epigenetics and gene expression,” explained Adrien Leger, PhD, Principal Research Scientist on Modified Bases...Yesterday, 07:01 AM -
Proteins are often described as the workhorses of the cell, and identifying their sequences is key to understanding their role in biological processes and disease. Currently, the most common technique used to determine protein sequences is mass spectrometry. While still a valuable tool, mass spectrometry faces several limitations and requires a highly experienced scientist familiar with the equipment to operate it. Additionally, other proteomic methods, like affinity assays, are constrained...04-04-2024, 04:25 PM
Comment